title: The effect of soybean-derived phosphatidylserine on cognitive performance in elderly with subjective memory complaints: a pilot study.
abstract: OBJECTIVE
  To evaluate the efficacy and safety of soybean-derived phosphatidylserine (SB-PS) (300 mg/day) in improving cognitive performance in elderly with memory complaints, following a short duration of 12 weeks' SB-PS administration.
  
  
  METHODS
  SB-PS was administered daily for 12 weeks to 30 elderly volunteers with memory complaints (age range 50-90 years). Cognitive performance was determined by a computerized test battery and by the Rey Auditory Verbal Learning Test (Rey-AVLT). Physical examination and blood safety parameters were part of the extensive safety analysis of PS that was performed.
  
  
  RESULTS
  The computerized test results showed that SB-PS supplementation significantly increased the following cognitive parameters: memory recognition (P = 0.004), memory recall (P = 0.006), executive functions (P = 0.004), and mental flexibility (P = 0.01). The Rey-AVLT indicated that, following SB-PS administration, total learning and immediate recall improved significantly (P = 0.013 and P = 0.007, respectively). Unexpected results from the safety tests suggested that SB-PS significantly reduces both systolic (P = 0.043) and diastolic (P = 0.003) blood pressure. SB-PS consumption was well tolerated and no serious adverse events were reported during the study.
  
  
  CONCLUSIONS
  This exploratory study demonstrates that SB-PS may have favorable effects on cognitive function in elderly with memory complaints. In addition, the study suggests that SB-PS is safe for human consumption and may serve as a safe alternative to phosphatidylserine extracted from bovine cortex. These results encourage further extended studies in order to establish the safety and efficacy of SB-PS treatment.
authors.affiliation: Enzymotec Ltd, K'far Baruch, Israel.
authors.forename: Yael
authors.initials: Y
authors.lastname: Richter
authors.forename: Yael
authors.initials: Y
authors.lastname: Herzog
authors.forename: Yael
authors.initials: Y
authors.lastname: Lifshitz
authors.forename: Rami
authors.initials: R
authors.lastname: Hayun
authors.forename: Sigalit
authors.initials: S
authors.lastname: Zchut
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000704:Analysis of Variance; D005260:Female; D015577:Geriatric Assessment; D006801:Humans; D008297:Male; D008569:Memory Disorders / Q000188:drug therapy*; D008875:Middle Aged; D009483:Neuropsychological Tests; D010718:Phosphatidylserines / Q000627:therapeutic use*; D010865:Pilot Projects; D013025:Glycine max / Q000737:chemistry*; D018709:Statistics, Nonparametric; D016896:Treatment Outcome
chemical_list: D010718:Phosphatidylserines
keywords: AAMI; cognitive; learning; memory; phosphatidylserine